Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia

Cancer Science

Volumn 100, Issue 12, 2009, Pages 2346-2353

  Hojjat Farsangi, Mohammad ^a   Jeddi Tehrani, Mahmood ^b,c   Razavi, Seyed Mohsen ^d   Sharifian, Ramazan Ali ^a   Mellstedt, Hakan ^c   Shokri, Fazel ^a,b,e   Rabbani, Hodjatallah ^b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CHAIN 1 2; IMMUNOGLOBULIN HEAVY CHAIN 1 69; IMMUNOGLOBULIN HEAVY CHAIN 1 8; IMMUNOGLOBULIN HEAVY CHAIN 3 21; IMMUNOGLOBULIN HEAVY CHAIN 3 30; IMMUNOGLOBULIN HEAVY CHAIN 3 48; IMMUNOGLOBULIN HEAVY CHAIN 3 7; IMMUNOGLOBULIN HEAVY CHAIN 4 34; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNOPHENOTYPING; IRAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROTEIN MOTIF; SEQUENCE HOMOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; B-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 70649087802     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01341.x     Document Type: Article

References (54)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005, 352:804-15.
2. Oscier DG, Gardiner AC, Mould SJ. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002, 100:1177-84.
3. Damle RN, Wasil T, Fais F. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-7.
4. Crespo M, Bosch F, Villamor N. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003, 348:1764-75.
5. Caporaso N, Goldin L, Plass C. Chronic lymphocytic leukaemia genetics overview. Br J Hematol 2007, 139:630-4.
6. Ghia P, Stamatopoulos K, Belessi C. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005, 105:1678-85.
7. Koiso H, Yamane A, Mitsui T. Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia. Leuk Res 2006, 30:272-6.
8. Donisi PM, Di Lorenzo N, Riccardi M. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy. Diagn Mol Pathol 2006, 15:206-15.
9. Rassenti LZ, Huynh L, Toy TL. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004, 351:893-901.
10. Montillo M, Hamblin T, Hallek M. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005, 90:391-9.
11. Vasconcelos Y, Davi F, Levy V. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J Clin Oncol 2003, 21:3928-32.
12. Maloum K, Davi F, Merle-Beral H. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000, 96:377-9.
13. Fais F, Ghiotto F, Hashimoto S. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998, 102:1515-25.
14. Rosenquist R, Lindstrom A, Holmberg D. V(H) gene family utilization in different B-cell lymphoma subgroups. Eur J Hematol 1999, 62:123-8.
15. Hamblin TJ, Davis Z, Gardiner A. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-54.
16. Duke VM, Gandini D, Sherrington PD. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003, 88:1259-71.
17. Messmer BT, Albesiano E, Messmer D. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004, 103:3490-5.
18. Widhopf GF, Rassenti LZ, Toy TL. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004, 104:2499-504.
19. Mauerer K, Zahrieh D, Gorgun G. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. Br J Hematol 2005, 129:499-510.
20. Tobin G, Thunberg U, Johnson A. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003, 101:4952-7.
21. Widhopf GF, Kipps TJ. Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 2001, 166:95-102.
22. Potter KN, Orchard J, Critchley E. Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood 2003, 101:3082-4.
23. Kipps TJ, Tomhave E, Pratt LF. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989, 86:5913-7.
24. Schroeder HW, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994, 15:288-94.
25. Tobin G, Thunberg U, Karlsson K. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004, 104:2879-85.
26. Pasqualucci L, Neri A, Baldini L. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. Cancer Res 2000, 60:5644-8.
27. Ghia EM, Jain S, Widhopf GF. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection. Blood 2008, 111:5101-8.
28. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001, eds, Lyon, France, IARC Press
29. Cheson BD, Bennett JM, Grever M. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996, 87:4990-7.
30. Jelinek DF, Tschumper RC, Geyer SM. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Hematol 2001, 115:854-61.
31. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-35.
32. Lossos IS, Tibshirani R, Narasimhan B. The inference of antigen selection on Ig genes. J Immunol 2000, 165:5122-6.
33. Messmer BT, Raphael BJ, Aerni SJ. Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia. Leuk Res 2009, 33:368-76.
34. Murray F, Darzentas N, Hadzidimitriou A. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008, 111:1524-33.
35. Matthews C, Catherwood MA, Morris TC. V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis. Leuk Res 2007, 31:231-4.
36. Nakahashi H, Tsukamoto N, Hashimoto Y. Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders. Cancer Sci 2009, 100:671-7.
37. Chen L, Zhang Y, Zheng W. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res 2008, 32:1491-8.
38. Farsangi MH, Jeddi-Tehrani M, Sharifian RA. Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia. Leuk Lymphoma 2007, 48:109-16.
39. Moazzeni SM, Amirzargar AA, Shokri F. HLA antigens in Iranian patients with B-cell chronic lymphocytic leukemia. Pathol Oncol Res 1999, 5:142-5.
40. Tamura K, Sawada H, Izumi Y. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Hematol 2001, 67:152-7.
41. Kraj P, Friedman DF, Stevenson F. Evidence for the overexpression of the VH4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire. J Immunol 1995, 154:6406-20.
42. Brezinschek HP, Foster SJ, Brezinschek RI. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest 1997, 99:2488-501.
43. Nardini E, Neri F, Vicenzi E. Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer 2003, 107:958-61.
44. Abramenko I, Bilous N, Kryachok I. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine. Exp Oncol 2007, 29:226-30.
45. Weinberg JB, Volkheimer AD, Chen Y. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. Am J Hematol 2007, 82:1063-70.
46. Guarini A, Chiaretti S, Tavolaro S. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood 2008, 112:782-92.
47. Rosenwald A, Alizadeh AA, Widhopf G. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001, 194:1639-47.
48. Stamatopoulos K, Belessi C, Moreno C. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007, 109:259-70.
49. Tobin G, Thunberg U, Johnson A. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002, 99:2262-4.
50. Degan M, Rupolo M, Bo MD. Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia. Clin Lymphoma 2004, 5:123-6.
51. Degan M, Bomben R, Bo MD. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Hematol 2004, 126:29-42.
52. Gallego A, Vargas JA, Castejon R. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL. Cytometry B Clin Cytom 2003, 56:23-9.
53. Suarez F, Lortholary O, Hermine O. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006, 107:3034-44.
54. Li HC, Stoicov C, Rogers AB. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 2006, 12:363-71.